How to buy Liquidia Corporation stock

Liquidia Corporation is a biotechnology business based in the US. Liquidia Corporation shares (LQDA) are listed on the NASDAQ and all prices are listed in US Dollars. Liquidia Corporation employs 51 staff and has a trailing 12-month revenue of around 0.00.

Liquidia Corporation share price

Use our graph to track the performance of LQDA stocks over time.

Liquidia Corporation shares at a glance

• Key figures

Information last updated 2021-04-29.

52-week range	$2.34 - $12.10
50-day moving average	$2.72
200-day moving average	$3.15
Wall St. target price	$4.50
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-2.51

Buy Liquidia Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Liquidia Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Liquidia Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Liquidia Corporation financials

Revenue TTM	$739,628
Gross profit TTM	$501,916
Return on assets TTM	-37.48%
Return on equity TTM	-112.72%
Profit margin	0%
Book value	$1.64
Market capitalisation	$147.2 million

TTM: trailing 12 months

Shorting Liquidia Corporation shares

There are currently 2.2 million Liquidia Corporation shares held short by investors – that's known as Liquidia Corporation's "short interest". This figure is 8% up from 2.0 million last month.

There are a few different ways that this level of interest in shorting Liquidia Corporation shares can be evaluated.

Liquidia Corporation's "short interest ratio" (SIR)

Liquidia Corporation's "short interest ratio" (SIR) is the quantity of Liquidia Corporation shares currently shorted divided by the average quantity of Liquidia Corporation shares traded daily (recently around 793413.18681319). Liquidia Corporation's SIR currently stands at 2.73. In other words for every 100,000 Liquidia Corporation shares traded daily on the market, roughly 2730 shares are currently held short.

However Liquidia Corporation's short interest can also be evaluated against the total number of Liquidia Corporation shares, or, against the total number of tradable Liquidia Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Liquidia Corporation's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Liquidia Corporation shares in existence, roughly 40 shares are currently held short) or 0.0486% of the tradable shares (for every 100,000 tradable Liquidia Corporation shares, roughly 49 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Liquidia Corporation.

Find out more about how you can short Liquidia Corporation stock.

Liquidia Corporation share dividends

We're not expecting Liquidia Corporation to pay a dividend over the next 12 months.

Liquidia Corporation share price volatility

Over the last 12 months, Liquidia Corporation's shares have ranged in value from as little as $2.34 up to $12.1. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Liquidia Corporation's is 0.0442. This would suggest that Liquidia Corporation's shares are less volatile than average (for this exchange).

Liquidia Corporation overview

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension; and LIQ865, a sustained-release formulation of bupivacaine for the treatment of local post-operative pain. The company also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. .

Frequently asked questions

• What percentage of Liquidia Corporation is owned by insiders or institutions?

  Currently 20.404% of Liquidia Corporation shares are held by insiders and 52.364% by institutions.

• How many people work for Liquidia Corporation?

  Latest data suggests 51 work at Liquidia Corporation.

• When does the fiscal year end for Liquidia Corporation?

  Liquidia Corporation's fiscal year ends in December.

• Where is Liquidia Corporation based?

  Liquidia Corporation's address is: 419 Davis Drive, Morrisville, NC, United States, 27560

• What is Liquidia Corporation's ISIN number?

  Liquidia Corporation's international securities identification number is: US53635D2027

• What is Liquidia Corporation's CUSIP number?

  Liquidia Corporation's Committee on Uniform Securities Identification Procedures number is: 53635D202